New mathematical model tracks how tumor environment impacts cancer therapies
Researchers from Mass General Brigham and the University of Cyprus have developed a sophisticated mathematical model to better understand how the tumor microenvironment affects the delivery and effectiveness of a new type of cancer therapy called an immunomodulatory antibody-drug conjugate (IM-ADC).
Read original article on The Medical News →Related news
-
Even short-term rises in air pollution are linked to more asthma emergency visits in Singapore
United Kingdom
-
Blood RNA markers may flag lung cancer risk 10 years before diagnosis
United Kingdom
-
Personalized navigation support increases genetic testing among cancer patients' relatives
United Kingdom
-
New AI framework personalizes supportive care for cancer survivors
United Kingdom
-
GLP-1s appear safe for treating diabetes in pregnancy, but evidence gaps remain
United Kingdom
-
Heart health guidance shifts focus from individual nutrients to overall diet quality
United Kingdom
-
Focusing on the 'obesity paradox' to improve cancer treatment success
United Kingdom
-
Focused brain radiation could ease severe, tough-to-treat depression
United Kingdom